Pregnancy hypertension · 2026
Feto-maternal outcomes in hypertensive disorders of pregnancy: a prospective community-based cohort study in rural central India.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jain Shuchi, Mor Shreya, Jain Manish, Shivkumar Poonam Varma, Mittal Gaurav
Аннотация
OBJECTIVE: To assess the prevalence of hypertensive disorders of pregnancy (HDP) and their impact on maternal and neonatal outcomes in a rural population of Central India.
STUDY DESIGN: A prospective, community-based cohort study was conducted over three years at a rural tertiary care centre, covering approximately 100,000 residents in 100 villages. A total of 1,650 pregnant women (<20 weeks of gestation) were enrolled through door-to-door surveys and followed monthly until one month postpartum. Data on maternal and neonatal outcomes were collected and analysed using SPSS 20.0, with p < 0.05 considered statistically significant.
MAIN OUTCOME MEASURES: Incidence and types of HDP; maternal complications; gestational age at delivery; mode and place of delivery; neonatal birth weight; neonatal morbidities; and perinatal mortality.
RESULTS: The incidence of HDP was 7.15% (118/1650). Gestational hypertension (non-severe features) was most common (53.4%), followed by preeclampsia with severe features (16.9%). Hypertensive women had significantly higher rates of infertility history (6.8% vs. 3%, p = 0.009) and previous child loss (6.8% vs. 2.48%, p = 0.006). Preterm delivery (<37 weeks) occurred in 17.8% of hypertensive women versus 8.03% in normotensive women (p = 0.0002). Cesarean section rates were higher in the HDP group (36.4% vs. 22%, p = 0.0001). Maternal complications such as anaemia (22.9% vs. 3.3%), thrombocytopenia (7.6% vs. 0.5%), and placental abruption (3.4% vs. 0.1%) were significantly more frequent. Neonates of hypertensive mothers had higher rates of low birth weight (35.6% vs. 22.5%), small for gestational age (53.4% vs. 19.8%), preterm birth (16.9% vs. 5.42%), and perinatal mortality (6.8% vs. 1.8%).
CONCLUSION: HDP significantly increases the risk of adverse maternal and neonatal outcomes, including preterm birth, cesarean delivery, low birth weight, and perinatal mortality. Early detection, close monitoring, and delivery in well-equipped tertiary centres are essential to improving fetomaternal outcomes, particularly in rural settings.
STUDY DESIGN: A prospective, community-based cohort study was conducted over three years at a rural tertiary care centre, covering approximately 100,000 residents in 100 villages. A total of 1,650 pregnant women (<20 weeks of gestation) were enrolled through door-to-door surveys and followed monthly until one month postpartum. Data on maternal and neonatal outcomes were collected and analysed using SPSS 20.0, with p < 0.05 considered statistically significant.
MAIN OUTCOME MEASURES: Incidence and types of HDP; maternal complications; gestational age at delivery; mode and place of delivery; neonatal birth weight; neonatal morbidities; and perinatal mortality.
RESULTS: The incidence of HDP was 7.15% (118/1650). Gestational hypertension (non-severe features) was most common (53.4%), followed by preeclampsia with severe features (16.9%). Hypertensive women had significantly higher rates of infertility history (6.8% vs. 3%, p = 0.009) and previous child loss (6.8% vs. 2.48%, p = 0.006). Preterm delivery (<37 weeks) occurred in 17.8% of hypertensive women versus 8.03% in normotensive women (p = 0.0002). Cesarean section rates were higher in the HDP group (36.4% vs. 22%, p = 0.0001). Maternal complications such as anaemia (22.9% vs. 3.3%), thrombocytopenia (7.6% vs. 0.5%), and placental abruption (3.4% vs. 0.1%) were significantly more frequent. Neonates of hypertensive mothers had higher rates of low birth weight (35.6% vs. 22.5%), small for gestational age (53.4% vs. 19.8%), preterm birth (16.9% vs. 5.42%), and perinatal mortality (6.8% vs. 1.8%).
CONCLUSION: HDP significantly increases the risk of adverse maternal and neonatal outcomes, including preterm birth, cesarean delivery, low birth weight, and perinatal mortality. Early detection, close monitoring, and delivery in well-equipped tertiary centres are essential to improving fetomaternal outcomes, particularly in rural settings.